arcoidosis is a multisystem granulomatous disease that afects 10-40 people per 100,000 in the United States and Europe, with an increased prevalence among blacks compared with whites. 1 Te clinical presentation of sarcoidosis is variable. Sarcoidosis frequently involves the lungs and can have numerous extrapulmonary manifestations including skin, joint, cardiac, and eye lesions. We present a rare case of sarcoidosis with concurrent third-degree heart block and warm autoimmune hemolytic anemia and discuss possible mechanisms behind this presentation.
Case presentation
In September 2014, a 30-year-old white woman with a 3-week history of increasingly frequent dizziness and near syncopal episodes presented to the hospital after 6 episodes of syncope in one day. At the time of admission, she reported having fevers, night sweats, and dark-colored urine for 4 weeks. She had an intentional 100-pound weight loss over the course of 1 year. Te patient had a past medical history of polysubstance abuse. During a previous admission for pneumonia in March 2014, a computerized tomography scan of her chest revealed difuse mediastinal lymphadenopathy and splenomegaly.
On admission, our patient was in third-degree heart block with a junctional escape rhythm and laboratory fndings consistent with warm autoimmune hemolytic anemia. Te results of a laboratory workup revealed hemoglobin of 7.9 g/dL (normal range, female, 12.1-15.1 g/dL); reticulocyte count, 14.4% (normal range, 0.5%-1.5%); lactate dehydrogenase, 302 U/L (105-333 U/L); haptoglobin, <30 mg/dL (normal range, female, 12.3-15.3 g/dL); white blood cell count, 5,700/mcL (4,500-10,000/mcL); platelet count, 261,000/mcL (150,000-400,000/mcL); positive direct and indirect Coombs tests; and positive warm antibodies. Antibody specifcity testing showed pan-agglutinin specifcity. Spherocytosis was seen on the peripheral smear. Electrolytes were within normal limits. Her liver function tests were Her diagnostic work-up was evaluated for infection, malignancy including lymphoma, sarcoidosis, and autoimmune causes. Te patient's test results for hepatitis C virus, human immunodefciency virus, Lyme disease, rapid plasma reagin for syphilis, tuberculosis, and blood cultures were all negative. She had a normal antinuclear antibody panel. Her serum angiotensin-converting enzyme level was 58 U/L (normal, 8-53 U/L).
Te transthoracic echocardiogram was negative for valvular vegetations and showed no structural cause for the third-degree heart block. Te patient's chest x-ray showed right hilar and mediastinal lymphadenopathy. Te results of a computerized tomography scan of the chest, abdomen, and pelvis showed splenomegaly and mediastinal, hilar, right axillary, and upper abdominal lymphadenopathy along with several new pulmonary nodules ( Figure  1) . A mediastinal lymph node biopsy revealed noncaseating granulomas consistent with sarcoidosis ( Figure 2 ). Te cultures for anaerobic, fungal, and acid-fast bacilli organisms had no growth. Given the patient's diagnosis of sarcoidosis and electrocardiogram fndings of third-degree heart block, mag- www.jcso-online.com Case Report netic resonance imaging of the heart was performed and was normal. An ophthalmologic exam showed no signs of ocular involvement from sarcoidosis.
To address her third-degree heart block, a temporary pacemaker was used and subsequently a dual chamber implantable cardioverter defbrillator was placed. Te patient was ultimately discharged from the hospital and was prescribed prednisone 60 mg daily for management of her newly diagnosed sarcoidosis. Results from an outpatient cardiac positron-emission tomography scan showed difuse myocardial glucose uptake, which suggested normal myocardial glucose metabolism. Perhaps, the negative PET scan was the result of the steroid therapy. Te warm autoimmune hemolytic anemia resolved with steroids. However, several liver function tests, specifcally AST and ALT, were further elevated to 313 U/L and 528 U/L, respectively.
Discussion
We present a rare case of sarcoidosis with concurrent thirddegree heart block and warm autoimmune hemolytic anemia. Sarcoidosis is a noncaseating, granulomatous disease of unknown etiology that can involve any organ within the body. We conducted a literature search for similar cases and found 11 reported instances of sarcoidosis with autoimmune hemolytic anemia. Other case reports describe additional associations with thrombocytopenia, 2 Hodgkin, 3 non-Hodgkin lymphoma, 4 and Sjögren's syndrome. 5 To our knowledge, this is the frst reported case of pulmonary sarcoidosis with concurrent third-degree heart block and warm autoimmune hemolytic anemia.
Sarcoidosis is thought to involve a type 1 T-lymphocyte response that is dependent on host susceptibility and characterized by chronic infammation, monocyte recruitment, and granuloma formation. 6 Remarkable progress has been made in our understanding of the immunopathogenesis of sarcoidosis. Tere is now consensus that sarcoidosis is a disease of enhanced, immunologic hypersensitivity to pathogenic tissue antigens. 7 Te clinical outcome of sarcoidosis can vary considerably. Two-thirds of patients with sarcoidosis generally have a remission within a decade after diagnosis, with few or no consequences. However, up to a third of patients have unrelenting disease leading to clinically signifcant organ impairment. 8 Treatment of the granulomatous infammation in sarcoidosis is dependent on nonspecifc suppression of the immune response. 9 Corticosteroids remain the initial treatment of choice for most patients with sarcoidosis due in large part to the clinical variability and high rates of spontaneous remission. 9 However, several other treatment modalities are commonly used. Although there is limited research in these areas, methotrexate is the most commonly used cytotoxic agent for chronic disease, 10 and the tumor necrosis factor antibody infiximab has proved useful in treating refractory sarcoidosis. 10 Of note is that although just over 10% of patients with sarcoidosis have elevated serum aminotransferase and alkaline phosphatase levels, liver involvement is usually clinically silent. 11 Our patient had elevation of serum aminotransferase and alkaline phosphatase. In about 5% of patients with sarcoidosis, granulomas can form in the liver. 12 Our patient is a young woman with biopsy-confrmed sarcoidosis who also shows clinical manifestations of atrioventricular block. With all other causes being excluded, it is presumed that she has cardiac sarcoidosis. Atrioventricular block is a common fnding in patients with clinically evident cardiac sarcoidosis. Prolongation of the PR interval due to disease of the atrioventricular node or bundle of His are common. 13 Although these lesions may initially be silent, they can progress to complete heart block and cause syncope.
14 Various defnitions and guidelines for diagnosing cardiac sarcoidosis have been proposed. Our patient had a histologic diagnosis of extracardiac sarcoid plus the presence of electrocardiograph abnormalities, which suggests that her heart block is of sarcoid etiology. Te most common location for granulomas and scars is the left ventricular free wall, followed by the intraventricular septum, often with involvement of the conducting system. 8 Te treatment of third-degree heart block focuses on treating the underlying cause and frequently involves pacemaker placement. Similarly, implantable cardioverter defbrillator (ICD) therapies in patients with cardiac sarcoidosis are common. An ICD is indicated for some patients with cardiac sarcoidosis for prevention of sudden death. 15 In addition to cardiac involvement, this patient also developed warm autoimmune hemolytic anemia. Autoimmune hemolytic anemia is a fairly uncommon disorder, with an estimated incidence of 1-3 cases per 100,000 people per year, 16 which makes the association of warm autoimmune hemolytic anemia with sarcoidosis a very rare phenomenon. Warm autoimmune hemolytic anemia occurs because of the presence of immunoglobulin G antibodies reacting with protein antigens on the surface of red blood cells at normal body temperature. Autoimmune hemolytic anemia is also thought to be the result of altered cell-mediated immunity with inadequate T-suppressor systems causing aberrant humoral immunity. 3 Treatment of autoimmune hemolytic anemia focuses on reduction of antibody production and antibody efectiveness. Te mainstay of treatment of newly diagnosed primary warm autoimmune hemolytic anemia is glucocorticoids. 17 Steroids help decrease the production of autoantibodies. Second-line therapy includes immunosuppressives, cytotoxic agents, splenectomy, and intravenous gamma globulin. In our patient, oral steroids addressed both her sarcoidosis and her hemolytic anemia.
Tis young woman's complete heart block seems to be the result of her biopsy-proven sarcoidosis. It is also possible that an immunologic mediator involved in the formation of granulomatous tissue triggered the warm autoimmune hemolytic anemia. In summary, the association of hematologic and other immune disorders with sarcoidosis may refect general antibody stimulation in sarcoidosis. 
